Chat with us, powered by LiveChat

Hospira’s generic antibiotic gets FDA green light

Hospira Inc. said Tuesday the Food and Drug Administration has approved its generic version of AstraZeneca’s antibiotic Merrem.

The FDA cleared Hospira’s version of intravenous meropenem in 500-milligram and 1-gram vials. Hospira said U.S. sales of Merrem totaled $200 million in 2009.

[Crain’s Chicago Business]